Jaguar Health Inc Stock Nasdaq
Equities
US47010C3007
Biotechnology & Medical Research
Sales 2022 | 11.96M 16.32M | Sales 2023 | 9.76M 13.33M | Capitalization | 7.68M 10.49M |
---|---|---|---|---|---|
Net income 2022 | -47M -64.17M | Net income 2023 | -41M -55.98M | EV / Sales 2022 | 4.65 x |
Net Debt 2022 | 29.37M 40.1M | Net Debt 2023 | 30.62M 41.81M | EV / Sales 2023 | 3.92 x |
P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.22% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.64% | 22.15B | |
-17.37% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |